IXICO PLC IXI.L

GBX6.83

Last Updated: May 15, 12:00 AM·LSE

IXI.L Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: January 22, 2026

Report Source: 2025 Annual Report

Analyst's Ratings for IXICO PLC (IXI.L)

Based on 9 analysts giving stock ratings to IXICO PLC in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
45
Buy
44
Hold
11
Sell
0
Strong Sell
0
IXICO PLC

IXICO PLC. Stock Analysis IXI.L

United Kingdom Health Care Nano Cap Report:
IXICO Plc engages in the provision of technology-enabled specialty services to the global biopharmaceutical industry. The firm is engaged in delivering insights in neuroscience to help transform the advancement of investigational therapies for neurological diseases, such as Alzheimer's disease, Parkinson's disease and Huntington's disease. The company advances medicine and human health by turning data into clinically meaningful information, providing new insights in neuroscience by supporting pharmaceutical companies across all phases of central nervous system (CNS) clinical research. Its services include imaging biomarkers, trial management, data analytics, consultancy and post-marketing surveillance. Its TrialTracker platform provides a standardized, compliant and efficient workflow for capturing visual read results of MRI, SPECT, PET and CT scans, supporting single, over-read and double adjudicated read paradigms.
Read More

Key Statistics of IXICO PLC (IXI.L)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

GBX6.50GBX7.08

Today's Open

GBX6.83

Volume

1520.00

P/E Ratio (TTM)

-

52 Week Range

GBX6.26GBX15.00

Market Cap

1.50B

Avg. Volume

80.25K

Dividend Yield

-

Financial Metrics & Statements of IXICO PLC (IXI.L)

Community-Curated Collections with IXICO PLC (IXI.L) ( With IXI.L )

View All

Community-Curated Collections are thoughtfully selected groups of stocks or assets, curated by investors and experts based on shared themes, values, or investment strategies.

FAQ's for IXICO PLC (IXI.L)

  • According to Musaffa’s Shariah screening methodology, IXICO PLC (IXI.L) is currently classified as NOT HALAL as of January 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.